Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Incomplete dose administered; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete dose administered in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. In JUN-2025, the patient received Shingrix. In JUN-2025, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: Incomplete dose administered). The outcome of the incomplete dose administered was not applicable. Additional Information: GSK receipt date- 24-SEP-2025 The reporter stated that, patient received half a dose of Shingrix instead of the full dose. The reporter did not know if that meant just that patient received just the adjuvant or half of the reconstituted vaccine. The dates of administration were between 23 June 2025 and 27 June 2025. The reporter consented to follow up. This was report 5 of 6. The batch number was not provided and a request for this information had been made.; Sender's Comments: US-GSK-US2025122806:Same reporter/Different patient US-GSK-US2025122818:Same reporter/Different patient US-GSK-US2025122804:Same reporter/Different patient US-GSK-US2025122805:Same reporter/Different patient GSK-US2025122808:Same reporter/Different patient